Welcome to 3i

For US regulatory reasons, US Residents are not to enter this site without the express permission of 3i Group plc, and 3i Group plc is not offering any securities or services in the United States or to US Residents through this site. (The term "US Residents" is defined in the detailed terms and conditions set out in the Terms and conditions page).

I am not a US resident (or I am, but I have 3i Group plc's express permission to use this site) and I accept the terms and conditions.

Terms and conditions

Degania Silicone Erezbit0138

Q Holding

  • Sector Healthcare
  • Year invested 2014
  • Location North America
  • Status Current

Q Holding is a global leading manufacturer of catheters and high-end materials science-based critical components and subassemblies for the medical devices industry. Headquartered in Ohio, it sells products in over 80 countries and has 13 manufacturing locations in North America, Europe and Asia.

Visit qmd.net

  • Qure Img 9794[1]
  • IMG 9529
  • Qsr Img 1491[1]

Overview

Q Holding has built a strong reputation as the supplier of choice to provide high-quality components that are mission critical. It has developed longstanding relationships with a broad range of blue chip customers who value their ability to develop such critical products and solutions. 

How we add value 

During our partnership, we have supported the acquisitions of Degania Medical (2016), a leading global manufacturer of catheters and other medical devices and Silicone Altimex (2015), a silicone provider of medical device components and pharmaceutical assemblies. 

We have supported the company's focus on achieving significant growth, driven by its differentiated product offering, high service levels and a strong end-market. 

We have also overseen the sale of Q Holding’s QSR division, a leading developer and manufacturer of electrical connector seals, for US$625m and the sale of the company's Precision Components Division, a leading provider of silicone and elastomeric molding and extrusion capabilities, for US$172m to focus the business on its core Catheter Technologies segment, which serves leading global OEMs with catheter solutions for the cardiovascular, vascular, enteral feeding, urology and general surgery markets. 

We have also built an experienced management team with a longstanding track record of driving innovation in product and service offering. 

Regulatory information
This transaction involved a recommendation of 3i Corporation.